Stage-dependent fate of Plasmodium falciparum-infected red blood cells in the spleen and sickle-cell trait-related protection against malaria
- Seidina A. S. Diakité†1, 2, 3,
- Papa Alioune Ndour†1, 3,
- Valentine Brousse4,
- Frederick Gay1,
- Camille Roussel1,
- Sylvestre Biligui1,
- Michaël Dussiot3, 5,
- Virginie Prendki1,
- Tatiana M. Lopera-Mesa6,
- Karim Traoré2,
- Drissa Konaté2,
- Saibou Doumbia2,
- Jérôme Cros7,
- Safi Dokmak7,
- Rick M. Fairhurst†6,
- Mahamadou Diakité†2 and
- Pierre A. Buffet1, 3Email author
© The Author(s) 2016
Received: 1 July 2016
Accepted: 6 September 2016
Published: 21 September 2016
Sickle-cell trait (HbAS) reduces falciparum malaria risk and suppresses parasitaemia. Although several candidate mechanisms have been proposed, their epidemiological, clinical and experimental correlates have not been adequately explained. To explore the basis for generally lower parasitaemias and delayed malaria episodes in children with HbAS, it is hypothesized here that their spleen-dependent removal of ring-infected red blood cells (RBCs) is more efficient than in children with normal haemoglobin A (HbAA).
The mechanical splenic retention of Plasmodium falciparum-infected RBCs from subjects with HbAS or HbAA was investigated using two physiologically relevant methods: microsphiltration and ex vivo spleen perfusion. P. falciparum-infected RBCs obtained from in vitro cultures and from patients were used in either normoxic or hypoxic conditions. The effect of sickling in ring-infected HbAS RBCs was also investigated.
When a laboratory-adapted parasite strain was analysed, ring-infected HbAA RBCs were retained in microsphilters at similar or greater levels than ring-infected HbAS RBCs, under normoxic (retention rate 62.5 vs 43.8 %, P < 0.01) and hypoxic (54.0 vs 38.0 %, P = 0.11) conditions. When parasitized RBCs from Malian children were analysed, retention of ring-infected HbAA and HbAS RBCs was similar when tested either directly ex vivo (32.1 vs 28.7 %, P = 0.52) or after one re-invasion in vitro (55.9 vs 43.7 %, P = 0.30). In hypoxia, sickling of uninfected and ring-infected HbAS RBCs (8.6 vs 5.7 %, P = 0.51), and retention of ring-infected HbAA and HbAS RBCs in microsphilters (72.5 vs 68.8 %, P = 0.38) and spleens (41.2 vs 30.4 %, P = 0.11), also did not differ. Retention of HbAS and HbAA RBCs infected with mature P. falciparum stages was greater than 95 %.
Sickle-cell trait is not associated with higher retention or sickling of ring-infected RBCs in experimental systems reflecting the mechanical sensing of RBCs by the human spleen. As observed with HbAA RBCs, HbAS RBCs infected with mature parasites are completely retained. Because the cytoadherence of HbAS RBCs infected with mature parasites is impaired, the very efficient splenic retention of such non-adherent infected RBCs is expected to result in a slower rise of P. falciparum parasitaemia in sickle-cell trait carriers.
KeywordsMalaria Plasmodium falciparum Sickle-cell trait Red blood cell Spleen Retention
Despite its deleterious consequences, haemoglobin S (HbS, β6 Glu → Val) has reached high prevalence in malaria-endemic areas [1, 2] due to its natural selection by falciparum malaria. HbS exists as a balanced polymorphism in sub-Saharan Africa, where it protects children with sickle-cell trait (HbAS heterozygotes) from falciparum malaria morbidity and mortality but causes sickle-cell disease in HbSS homozygotes . While HbAS children are protected from severe malaria, uncomplicated malaria, and high parasitaemia [4–8] compared to HbAA children, the mechanisms that mediate these protections remain under active investigation. Although several candidate mechanisms have been proposed [9–11], their epidemiological, clinical and experimental correlates have not been adequately explained. For example, Malian HbAS children experience their first malaria episode about 1 month later in the transmission season compared to HbAA children, despite these two groups of children having a comparable parasitaemia at the time of their first malaria episode .
To explore the basis for generally lower parasitaemias and delayed malaria episodes in HbAS children, it is hypothesized here that their spleen-dependent removal of ring-infected red blood cells (RBCs) is more efficient than in HbAA children. Such an effect would achieve a lower parasitaemia that would be tolerated without symptoms, and delay progression to a higher parasitaemia that produces symptoms [13, 14]. A slower rise in parasitaemia in HbAS children may conceivably result from an enhanced adaptive immune response to P. falciparum antigens or from a more effective innate clearance of circulating infected RBCs in the spleen, as suggested by enhanced phagocytosis of ring-infected HbAS RBCs in vitro . While several studies have reported no differences between HbAS and HbAA children in the intensity of adaptive immune responses to parasite antigens [16–18], others have reported some differences .
In exploring a protective role for the spleen, one potentially relevant observation is that HbAS RBCs are less deformable than HbAA RBCs, evidenced in part by their greater retention in leukocyte-depletion filters . Also, P. falciparum ring-infected HbAS RBCs were found to sickle faster than uninfected HbAS RBCs when treated with reducing agents or exposed to very low O2 concentrations [21, 22]. Given these findings, investigators have long speculated that the spleen’s preferential destruction of sickled, ring-infected HbAS RBCs may protect HbAS children from clinical malaria and high parasitaemia. Alternatively, since the cytoadherence of HbAS RBCs infected with mature parasites is significantly impaired [23, 24], the splenic retention and destruction of such non-adherent infected RBCs may result in a slower rise of P. falciparum parasitaemia in sickle-cell trait carriers. Retention of infected RBCs in the spleen may involve both biomechanical processes and cell–cell adhesion between infected RBCs and splenic structures. However, consistent with the absence of detectable parasite proteins on the surface of ring-infected RBCs, their retention in isolated-perfused spleens (performed in the absence of plasma or antibodies) is biomechanical in nature .
Taking advantage of recent progress in studying splenic retention in vitro and ex vivo , these possibilities were investigated using validated tools, such as ektacytometry, microsphiltration and human spleen perfusion under conditions that induce or do not induce the sickling of uninfected and infected HbAS RBCs.
HbAA and HbAS RBCs were collected in Mali and France. In Mali, blood donors were children who participated in a cohort study of genetic and acquired protection from falciparum malaria , and were found to be healthy and aparasitaemic at the time of blood collection. This study is registered at Clinicaltrials.gov (NCT00669084) and was approved by the Institutional Review Board (IRB) of the National Institute of Allergy and Infectious Diseases, US National Institutes of Health, and the Ethics Committee of the Faculty of Medicine, Pharmacy and Odontostomatology, University of Bamako. The parents of all children gave written informed consent.
In France, HbAS and HbSS RBCs were collected at the Necker Hospital from HbAS parents or HbSS children who were identified through routine haemoglobinopathy screening and prenatal counselling programmes; in all cases, parents provided written informed consent for the use of left-over blood samples. HbAA RBCs were collected from healthy donors in parallel. These sample collections were approved by the IRB of Paris VI University. The Ile de France VI IRB has approved this approach as a non-research process (Article L1121-1, French Code for Public Health).
All venous blood samples were collected in ACD Vacutainers® (Becton–Dickinson, Rungis, France) and washed three times with RPMI-1640 (Life Technologies, Saint-Aubin, France) to remove the buffy coat and plasma. RBCs were stored at 4 °C and used within 24 h.
Plasmodium falciparum strains and culture
Trophozoite stages of the P. falciparum laboratory line FUP and Malian P. falciparum clinical isolates (prepared by collecting ring stages from children with malaria and culturing them ex vivo) were purified using MACS columns (Miltenyi Biotec, San Diego, CA, USA), inoculated into fresh HbAA, HbAS and HbSS RBCs in parallel, and then studied at the ring stage. In some experiments, parasites were allowed to mature for 36 h to the trophozoite stage before being used in filtration experiments.
In France, parasites were cultured at 2 % haematocrit in RPMI-1640 media containing 25 mM HEPES, 25 mM NaHCO3, 0.3 g/L glutamine, 10 mg/L gentamicin (Life Technologies) and 10 % human AB+ serum, and incubated at 37 °C in an atmosphere of 21 % O2, 5 % CO2 and 74 % N2. In Mali, parasites were cultured similarly, except that 0.5 % AlbuMAX® II (Life Technologies) was used to supplement the media instead of human AB+ serum.
Calibrated metal microbeads (microspheres) composed of 96.5 % tin, 3.0 % silver and 0.5 % copper were used to reconstitute very narrow spaces mimicking the inter-endothelial slit of the human spleen red pulp micro vein (sinus). Microspheres were obtained from Industrie des Poudres Sphériques (24A, rue de la Résistance-BP 438, Annemasse 74108, France). Two different size distributions (5- to 15-μm diameter and 15- to 25-μm diameter) were used throughout. A total of 1 g of dry microspheres of each sort was mixed and then suspended in 5 mL of phosphate-buffered saline (PBS)/1 % AlbuMAX II (Invitrogen). A total of 800 μL of this microsphere suspension was poured into an inverted 1000-μL anti-aerosol pipette tip (Neptune, BarrierTips) and allowed to settle, leading to the formation of a 5-mm thick microsphere layer above the anti-aerosol filter.
A total of 600 µL of RBC suspension (2 % haematocrit in PBS/1 % AlbuMAX® II) was instantaneously introduced upstream from the microsphere layer. The microsphere layer was then washed with 6 mL of PBS/1 % AlbuMAX II using an electric pump (Syramed μsp6000, Arcomed’Ag) at a flow rate of 60 mL/h. The downstream sample (6.6 mL) and an aliquot from the upstream sample were analysed. In some experiments, hypoxic conditions were created by gassing the RBC suspension and the PBS/1 % AlbuMAX® II solution with a gas mixture of 1 % O2, 5 % CO2 and 94 % N2 for 15 min and microsphiltration was performed in a hermetic plastic tent (Captair Pyramid®; Erlab, Val de Reuil, France) that was inflated, deflated and re-inflated with the same gas mixture prior to each experiment (Additional file 1). Maintenance of 1 % O2 and 5 % CO2 levels in the RBC suspension was confirmed every 15–30 min using an i-STAT® System and CG4+ cartridge (Abbott Point of Care, Princeton, NJ, USA). The mean parasitaemias (per cent of infected RBCs in the RBC suspension) in the upstream (U) and downstream (D) samples were determined for duplicate samples. The RBC retention rate (RR) for each sample was calculated using the following formula: RR = [(U−D)/U] × 100.
Uninfected and ring-infected RBCs were labelled with SYTO® 61 red fluorescent nucleic acid stain (Life Technologies) to detect parasite DNA. Briefly, 100 µL of RBCs were incubated in 1 mL of a 1/1000 dilution of SYTO61 in PBS/2 % AlbuMAX solution for 15 min. The RBCs were then washed three times with PBS and PKH26 (red) or PKH67 (green) lipophilic fluorescent cell linker probes were used to label HbAS and HbAA RBC membranes, respectively, according to the manufacturer’s instructions (Sigma-Aldrich, Saint-Quentin, France). Cell counting was performed using an Accuri C6 flow cytometer (Becton–Dickinson), and 20,000 events were recorded.
Sickling in stringent hypoxic conditions followed by microsphiltration
To investigate the influence of hypoxia-induced sickling on the retention of ring-infected RBCs, these cells were suspended at 2 % haematocrit in PBS/1 % AlbuMAX® II and exposed to a gas mixture containing a lower O2 concentration (0.5 % O2, 5 % CO2 and 94.5 % N2) supplemented with 2 L of CO2 within a hermetic plastic tent. The final concentration of CO2 in the tent was 6.5 %. The variation of dissolved CO2 and O2 partial pressures was measured using an i-STAT® System and CG4+ cartridge (Abbott Point of Care, Princeton, NJ, USA). At 0, 5, 15, 30 and 45 min after exposure to the gas mixture, 500-µL samples were fixed in 500 µL of 1 % glutaraldehyde for up to 15 min, pelleted and used to prepare a thin smear on a glass slide. The slide was then labelled with 1:1500 Hoechst 33,342 stain (H3570; Molecular Probes, Inc, Eugene, OR, USA) in PBS/1 % AlbuMAX® II for 30 min, washed four times with 1X PBS, and covered with VECTASHIELD® anti-fade mounting media for fluorescence (Vector Laboratories, Burlingame, CA, USA) and a cover slide. Using a fluorescence microscope, RBCs were observed under red fluorescence and parasite DNA under UV fluorescence. Images were acquired on a Leica DMI3000 microscope, using a Leica DFC310FX camera controlled by LAS Superposition Images software (Leica Microsystems, Nanterre, France). Uninfected RBCs and ring-infected RBCs were separately categorized into three groups: discoid RBCs, sickled RBCs, or indeterminate RBCs that were neither discoid nor sickled. To validate cell counts by microscopy, discoid RBCs, sickled RBCs, discoid ring-infected RBCs, and sickled ring-infected RBCs were also quantified using imaging flow cytometry as previously described . Briefly, glutaraldehyde-fixed RBCs were passed through an Image Stream Mark II Imaging Flow Cytometer (EMD Millipore, Billerica, MA, USA) and 50,000 events acquired using Inspire V4.0 software. Post-acquisition data analysis was performed using IDEAS V6.2 software. An algorithm that correctly differentiates discoid and sickled RBCs was created. Sickling rates were calculated by dividing the number of sickled RBCs by all RBCs (i.e., discoid + sickled + indeterminate RBCs).
Human spleen retrieval and ex vivo spleen perfusion
Human spleens were retrieved from patients undergoing splenopancreatectomy for pancreatic diseases and processed as previously described . Briefly, medical and surgical care was not modified, and written informed consent was obtained from all patients. The study was approved by the Ile-de-France II IRB. The main splenic artery was cannulated, and the spleen flushed with RPMI-1640 containing 0.3 % Albumax II and 1 µg/L gentamicin (Life Technologies), transferred to the laboratory, and connected to the perfusion device. Fresh HbAA and HbAS RBCs were inoculated with mature-stage MACS-purified P. falciparum and incubated for 12–36 h at 37 °C in an atmosphere of 21 % O2 and 5 % CO2 until reinvasion occurred. The two RBC populations were then differentially labelled with two lipophilic fluorescent cell-linker probes: PKH26 for HbAA RBCs and PKH67 for HbAS RBCs. The two labelled RBC suspensions were then mixed with fresh RBCs (French Blood Establishment, Rungis, France) to achieve a 15–25 % haematocrit. The mixture was then perfused into the spleen ex vivo using the perfusion device. During perfusion, key physiologic markers (TO2, TCO2, glucose, lactate) were maintained at physiological levels. Spleen effluents were sampled at various time points during perfusion. Fluorescence signals of the HbAA RBC and HbAS RBC populations were detected and the parasitaemia of each RBC population determined by flow cytometry as described above. The relative retention rates were then calculated as described above. Relative retention rate is defined here as retention of ring-infected HbAA RBCs in all (infected and uninfected) HbAA RBCs from the same culture or retention of ring-infected HbAS RBCs in all (infected and uninfected) HbAS RBCs from the same culture (see Additional files 2, 3). The retention rate at the end of the perfusion (at 60 min) was considered the retention rate in the spleen.
Statistical analysis was performed using GraphPad Prism 6 software (GraphPad, San Diego, CA, USA). The Mann–Whitney test, Kruskal–Wallis test, or t test with Welch’s correction were used, as appropriate. All P values are two-tailed and deemed significant when <0.05.
Retention of Plasmodium falciparum ring-infected HbAA and HbAS RBCs
Hypoxia-induced sickling of ring-infected and uninfected RBCs
Effect of sickling-inducing hypoxia on the retention of ring-infected HbAA and HbAS RBCs
Retention of mature Plasmodium falciparum-infected HbAA and HbAS RBCs
HbAA and HbAS RBCs were inoculated with P. falciparum, cultured in vitro for 36 h until parasites matured to the trophozoite stage and filtered. In four independent experiments, essentially all of the mature P. falciparum-infected HbAS and HbAA RBCs were retained in the microsphilters (Fig. 3d).
This study shows that ring-infected HbAS RBCs displayed retention rates that were similar or lower than those of ring-infected HbAA RBCs in vitro (microsphiltration) and ex vivo (perfused human spleens). To mimic the situation occurring in human subjects, experiments were performed with HbAA rings mixed in HbAA RBCs or HbAS rings mixed in HbAS RBCs. This finding was unexpected given that uninfected HbAS RBCs are less deformable than uninfected HbAA RBCs [13, 14] (Additional file 4). It was thus conceivable that, after being invaded by P. falciparum and subjected to the effects of initial parasite development, ring-infected HbAS RBCs would become even less deformable than uninfected HbAS RBCs and thereby more retained in microsphilters and human spleens. Despite this logical assumption, ring-infected HbAS RBCs were not more retained than ring-infected HbAA RBCs in microsphilters. This observation, which was initially made using the P. falciparum FUP strain in normoxic conditions, was reproduced in microsphilters using the FUP strain in moderately hypoxic conditions (1 % O2, 3 % CO2 and 96 % N2) and multiple parasite isolates from Malian children in normoxic conditions either before or after in vitro cultivation.
Together, these data suggest that sickle-cell trait does not suppress parasitaemia by enhancing the mechanical retention of ring-infected RBCs in the spleen. While the retention of ring-infected RBCs was partial in these experimental systems that mimic the mechanical sensing of RBCs by the spleen, mechanical retention of HbAS RBCs infected with mature parasites was very effective and complete, as previously observed with P. falciparum-infected HbAA RBC [25, 26]. Because the cytoadherence of HbAS RBCs infected with mature parasites is impaired , it is proposed here that the very efficient splenic retention of such non-adherent infected RBCs may result in a slower rise of P. falciparum parasitaemia in sickle-cell trait carriers.
The aforementioned experiments assumed that the microsphilter retention of ring-infected RBCs results from parasite-induced alterations in the shape or membrane rigidity of ring-infected RBCs [14, 29]. However, increased rigidity of ring-infected HbAS RBCs may also result from parasite-induced sickling, which increases their cytoplasmic viscosity. Previous studies of HbAS RBCs ex vivo  and in vitro  reported enhanced sickling of ring-infected RBCs as compared to uninfected RBCs, and thus speculated that HbAS (but not HbAA) children benefitted from enhanced destruction of ring-infected RBCs in their spleens. To test this possibility, the mechanical retention of ring-infected HbAS (and HbSS) RBCs was investigated in experimental conditions that induced sickling. When exposed to sickling-inducing, physiologically-relevant gas mixtures, both uninfected and ring-infected HbAS and HbSS RBCs showed no differences in their sickling rates. Even under conditions that induced high sickling rates, the retention rates of ring-infected HbAS and HbAA RBCs were similar. These results, which were obtained at O2 and CO2 concentrations observed in the venous effluent of human spleens perfused ex vivo  and without reducing agents, differ strikingly from previous observations [21, 22] and are in agreement with pioneering explorations on this topic . Together, these data suggest that sickle-cell trait does suppress parasitaemia by enhancing the retention of sickled, ring-infected RBCs in the spleen.
These observations suggest a very important role of the spleen in controlling parasite load in HbAS children by the efficient retention and phagocytosis of those mature trophozoite-infected RBCs that fail to cytoadhere .
SASD, PAN, VB, RMF, MD and PAB designed the study. SASD, PAN, SB, VP and TML-M performed filtration experiments. VB, KT, DK and SDou collected blood samples. JC and SDok collected spleen samples. SASD, PAN and PAB performed the spleen perfusion experiments. SASD, CR and MDu performed the imaging flow cytometry experiments. SASD, PAN, FG, CR and PAB analysed data. RMF, MDi and PAB supervised the study. SASD, PAN, RMF, MDi and PAB wrote the manuscript. All authors read and approved the final manuscript.
We thank the patients and healthy blood donors for participating in this study; the French National Reference Centre for collecting P. falciparum clinical isolates; the Necker Hospital staff for collecting blood samples; Profs Béatrice Aussilhou and Alain Sauvanet (Service de Chirurgie Digestive et Viscérale, Hôpital Beaujon, AP-HP, Clichy, France) for retrieving human spleens; Drs Jennifer Anderson and Dick Sakai for providing logistical support; Liliane Ciceron for providing technical assistance; Drs Mory Doumbouya, Ibrahim Sanogo, Ismaila Coulibaly and Abdoul Keita for collecting blood samples and managing patients in Mali.
The authors have declared that they have no competing interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Availability of data and materials
All the data and material reported in this manuscript are available.
Consent for publication
Consent forms state that data may be published in an international reviewed journal.
Ethics approval and consent to participate
The French study is part of an observational program implemented by the National Reference Centre (CNR) for Malaria, on behalf of Agence National de Sécurité du Médicament. Patients provided consent according to a procedure common to all French National Reference Centres (http://www.invs.sante.fr/CNR/). The Malian study is registered at Clinicaltrials.gov (NCT00669084) and was approved by the IRB of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and the Ethics Committee of the Faculty of Medicine, Pharmacy and Odontostomatology, University of Bamako. The parents of all children gave written informed consent.
This work was supported by the DIM Mal Inf Région Ile de France; the Intramural Research Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health; the Bill and Melinda Gates Foundation (to PAN). SASD and PAN were additionally supported by the Laboratoire d’Excellence du Globule Rouge (Labex GR-Ex), Paris, France.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Allison AC. The distribution of the sickle-cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria. Trans R Soc Trop Med Hyg. 1954;48:312–8.View ArticlePubMedGoogle Scholar
- Piel FB. Sickle-cell disease: geographical distribution and population estimates. Med Sci. 2013;29:965–7 (in French).Google Scholar
- Williams TN. Sickle cell disease in sub-Saharan Africa. Hematol Oncol Clin North Am. 2016;30:343–58.View ArticlePubMedGoogle Scholar
- Taylor SM, Parobek CM, Fairhurst RM. Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:457–68.View ArticlePubMedPubMed CentralGoogle Scholar
- Lopera-Mesa TM, Doumbia S, Konate D, Anderson JM, Doumbouya M, Keita AS, et al. Impact of red blood cell variants on childhood malaria in Mali: a prospective cohort study. Lancet Haematol. 2015;2:e140–9.View ArticlePubMedPubMed CentralGoogle Scholar
- May J, Evans JA, Timmann C, Ehmen C, Busch W, Thye T, et al. Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA. 2007;297:2220–6.View ArticlePubMedGoogle Scholar
- Lederberg JJBS. Haldane (1949) on infectious disease and evolution. Genetics. 1999;153:1–3.PubMedPubMed CentralGoogle Scholar
- Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet. 2002;359:1311–2.View ArticlePubMedGoogle Scholar
- Bunn HF. The triumph of good over evil: protection by the sickle gene against malaria. Blood. 2013;121:20–5.View ArticlePubMedGoogle Scholar
- Gong L, Parikh S, Rosenthal PJ, Greenhouse B. Biochemical and immunological mechanisms by which sickle cell trait protects against malaria. Malar J. 2013;12:317.View ArticlePubMedPubMed CentralGoogle Scholar
- Taylor SM, Cerami C, Fairhurst RM. Hemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesis. PLoS Pathog. 2013;9:e1003327.View ArticlePubMedPubMed CentralGoogle Scholar
- Crompton PD, Traore B, Kayentao K, Doumbo S, Ongoiba A, Diakite SA, et al. Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. J Infect Dis. 2008;198:1265–75.View ArticlePubMedPubMed CentralGoogle Scholar
- Buffet PA, Safeukui I, Deplaine G, Brousse V, Prendki V, Thellier M, et al. The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood. 2011;117:381–92.View ArticlePubMedPubMed CentralGoogle Scholar
- Buffet PA, Safeukui I, Milon G, Mercereau-Puijalon O, David PH. Retention of erythrocytes in the spleen: a double-edged process in human malaria. Curr Opin Hematol. 2009;16:157–64.View ArticlePubMedGoogle Scholar
- Ayi K, Turrini F, Piga A, Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood. 2004;104:3364–71.View ArticlePubMedGoogle Scholar
- Tan X, Traore B, Kayentao K, Ongoiba A, Doumbo S, Waisberg M, et al. Hemoglobin S and C heterozygosity enhances neither the magnitude nor breadth of antibody responses to a diverse array of Plasmodium falciparum antigens. J Infect Dis. 2011;204:1750–61.View ArticlePubMedPubMed CentralGoogle Scholar
- Le Hesran JY, Personne I, Personne P, Fievet N, Dubois B, Beyeme M, et al. Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait. Int J Epidemiol. 1999;28:793–8.View ArticlePubMedGoogle Scholar
- Allen SJ, Bennett S, Riley EM, Rowe PA, Jakobsen PH, O’Donnell A, et al. Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia. Trans R Soc Trop Med Hyg. 1992;86:494–8.View ArticlePubMedGoogle Scholar
- Verra F, Simpore J, Warimwe GM, Tetteh KK, Howard T, Osier FH, et al. Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria. PLoS ONE. 2007;2:e978.View ArticlePubMedPubMed CentralGoogle Scholar
- Brandao MM, Saad ST, Cezar CL, Fontes A, Costa FF, Barjas-Castro ML. Elastic properties of stored red blood cells from sickle trait donor units. Vox Sang. 2003;85:213–5.View ArticlePubMedGoogle Scholar
- Luzzatto L, Nwachuku-Jarrett ES, Reddy S. Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait. Lancet. 1970;1:319–21.View ArticlePubMedGoogle Scholar
- Roth EF Jr, Friedman M, Ueda Y, Tellez I, Trager W, Nagel RL. Sickling rates of human AS red cells infected in vitro with Plasmodium falciparum malaria. Science. 1978;202:650–2.View ArticlePubMedGoogle Scholar
- Cholera R, Brittain NJ, Gillrie MR, Lopera-Mesa TM, Diakite SA, Arie T, et al. Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci USA. 2008;105:991–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Opi DH, Ochola LB, Tendwa M, Siddondo BR, Ocholla H, Fanjo H, Ghumra A, et al. Mechanistic studies of the negative epistatic malaria-protective interaction between sickle cell trait and alpha + thalassemia. EBioMedicine. 2014;1:29–36.View ArticlePubMedGoogle Scholar
- Safeukui I, Correas JM, Brousse V, Hirt D, Deplaine G, Mule S, et al. Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen. Blood. 2008;112:2520–8.View ArticlePubMedGoogle Scholar
- Deplaine G, Safeukui I, Jeddi F, Lacoste F, Brousse V, Perrot S, et al. The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro. Blood. 2011;117:e88–95.View ArticlePubMedPubMed CentralGoogle Scholar
- van Beers EJ, Samsel L, Mendelsohn L, Saiyed R, Fertrin KY, Brantner CA, et al. Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease. Am J Hematol. 2014;89:598–603.View ArticlePubMedPubMed CentralGoogle Scholar
- Buffet PA, Milon G, Brousse V, Correas JM, Dousset B, Couvelard A, et al. Ex vivo perfusion of human spleens maintains clearing and processing functions. Blood. 2006;107:3745–52.View ArticlePubMedGoogle Scholar
- Mohandas N, Groner W. Cell membrane and volume changes during red cell development and aging. Ann N Y Acad Sci. 1989;554:217–24.View ArticlePubMedGoogle Scholar
- Miller MJ, Neel JV, Livingstone FB. Distribution of parasites in the red cells of sickle-cell trait carriers infected with Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1956;50:294–6.View ArticlePubMedGoogle Scholar